These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 12845379)

  • 1. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.
    Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE
    Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
    Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.
    Kawamata J; Tanaka S; Shimohama S; Ueda K; Kimura J
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1414-6. PubMed ID: 7964823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
    McCusker SM; Curran MD; Dynan KB; McCullagh CD; Urquhart DD; Middleton D; Patterson CC; McIlroy SP; Passmore AP
    Lancet; 2001 Feb; 357(9254):436-9. PubMed ID: 11273064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
    Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
    Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
    Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations.
    Martínez S; Ochoa B; Pérez MR; Torrico F; García I; Garcia CC
    Biomedica; 2022 May; 42(Sp. 1):116-129. PubMed ID: 35866735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
    Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
    J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
    Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
    Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians.
    Panza F; Solfrizzi V; Torres F; Mastroianni F; Del Parigi A; Colacicco AM; Basile AM; Capurso C; Noya R; Capurso A
    Neurosci Lett; 1999 Dec; 277(1):53-6. PubMed ID: 10643896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients.
    Palumbo B; Parnetti L; Nocentini G; Cardinali L; Brancorsini S; Riccardi C; Senin U
    Neurosci Lett; 1997 Aug; 231(1):59-61. PubMed ID: 9280168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults.
    Lamar M; Yu L; Rubin LH; James BD; Barnes LL; Farfel JM; Gaiteri C; Buchman AS; Bennett DA; Schneider JA
    Alzheimers Dement; 2019 Feb; 15(2):258-266. PubMed ID: 30321502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.